Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06684899
What this trial is testing

Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients

Who this might be right for
GlioblastomaCytokine-Induced Killer Cells
IRCCS San Raffaele 40
Early research (Phase 1)Ended earlyNCT01702792
What this trial is testing

Derivation of Tumor Specific Hybridomas

Who this might be right for
Glioblastoma
Dartmouth-Hitchcock Medical Center 1
Not applicableNot Yet RecruitingNCT06017063
What this trial is testing

Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields

Who this might be right for
Compliance, PatientGlioblastomaAstrocytoma, Grade IV
University Hospital Tuebingen 275
Testing effectiveness (Phase 2)Study completedNCT00010036
What this trial is testing

Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07392957
What this trial is testing

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 54
Early research (Phase 1)Study completedNCT00612001
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)WithdrawnNCT03649464
What this trial is testing

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Who this might be right for
GlioblastomaAstrocytomaOligodendroglioma
Oblato, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05074992
What this trial is testing

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University College, London 1
Early research (Phase 1)Study completedNCT02270034
What this trial is testing

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme (Grade IV) of Cerebellum
Grupo Español de Investigación en Neurooncología 38
Testing effectiveness (Phase 2)WithdrawnNCT03506139
What this trial is testing

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
John M. Buatti
Testing effectiveness (Phase 2)Ended earlyNCT02525692
What this trial is testing

Oral ONC201 in Adult Recurrent Glioblastoma

Who this might be right for
GlioblastomaDiffuse Midline GliomaH3 K27M Glioma+3 more
Jazz Pharmaceuticals 84
Early research (Phase 1)Study completedNCT04295759
What this trial is testing

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Pediatric Brain Tumor Consortium 13
Testing effectiveness (Phase 2)Study completedNCT00047073
What this trial is testing

Sirolimus in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 13
Early research (Phase 1)UnknownNCT03734913
What this trial is testing

ZSP1602 in Participants With Advanced Solid Tumors

Who this might be right for
Basal Cell CarcinomaMedulloblastomaAdenocarcinoma of Esophagogastric Junction+3 more
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 65
Testing effectiveness (Phase 2)Study completedNCT02895360
What this trial is testing

Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma

Who this might be right for
Neoplasms
Basilea Pharmaceutica 43
Testing effectiveness (Phase 2)WithdrawnNCT02754362
What this trial is testing

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioma
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT06186440
What this trial is testing

Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Zhongnan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00200161
What this trial is testing

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Who this might be right for
GlioblastomaGliomas
Memorial Sloan Kettering Cancer Center 127
Testing effectiveness (Phase 2)Study completedNCT04417088
What this trial is testing

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Who this might be right for
Recurrent Glioblastoma
InSightec 28
Testing effectiveness (Phase 2)Ended earlyNCT00376103
What this trial is testing

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Methodist Healthcare - Memphis 3
Next Page